Haemonetics Corp
HAE- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000313143
No open-market purchases or sales by Haemonetics Corp insiders were filed in the last 90 days; 329 institutions reported holding it in 13F filings for Q2 2026, worth $3.71B in total; no superinvestor holds it.
Holders of 5% or more of HAE
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Haemonetics Corp, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Haemonetics Corp on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on Haemonetics Corp, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 12, 202510:34 AM ET | Wellington Management Group LLPand 2 others | 13G/A | 4.60%2.20M shares | −0.80 ppfrom 5.40%Below 5% | Jun 30, 2025 | SEC |
| May 14, 202510:47 AM ET | T. Rowe Price Investment Management, Inc. | 13G/A | 4.40%2.20M shares | –Below 5% | Mar 31, 2025 | SEC |
| May 12, 202510:44 AM ET | Wellington Management Group LLPand 2 others | 13G/A | 5.40%2.69M shares | – | Mar 31, 2025 | SEC |
| Apr 4, 20254:24 PM ET | Capital Research Global Investors | 13G/A | 3.10%1.58M shares | –Below 5% | Mar 31, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Haemonetics Corp shares.
No Form 144 notices for Haemonetics Corp are on file.